Location: Dallas, TX
CIK: 0001617201 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $362M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GLPG | GALAPAGOS NV | 1,025,000 | $28.19M | 7.8% | $37.79 | — | SPON ADR | 36315X101 |
| ACHC | ACADIA HEALTHCARE COMPANY IN | 692,000 | $27.44M | 7.6% | $45.33 | -0.5% | COM | 00404A109 |
| BBIO | BRIDGEBIO PHARMA INC | 995,000 | $27.3M | 7.5% | $30.67 | -15.7% | COM | 10806X102 |
| MGTX | MEIRAGTX HLDGS PLC | 4,390,837 | $26.74M | 7.4% | $7.18 | -18.4% | COM | G59665102 |
| ABCL | ABCELLERA BIOLOGICS INC | 7,350,000 | $21.54M | 6.0% | $3.80 | -26.6% | COM | 00288U106 |
| ADCT | ADC THERAPEUTICS SA | 9,515,000 | $18.93M | 5.2% | $3.21 | -18.5% | SHS | H0036K147 |
| MIRM | MIRUM PHARMACEUTICALS INC | 451,127 | $18.65M | 5.2% | $29.75 | +40.1% | COM | 604749101 |
| ICLR | ICON PLC | 85,000 | $17.83M | 4.9% | $233.52 | 0.0% | SHS | G4705A100 |
| ROIV | ROIVANT SCIENCES LTD | 1,500,000 | $17.75M | 4.9% | $10.80 | +9.5% | SHS | G76279101 |
| JANX | JANUX THERAPEUTICS INC | 329,768 | $17.66M | 4.9% | $47.06 | +12.4% | COM | 47103J105 |
| SDGR | SCHRODINGER INC | 720,500 | $13.9M | 3.8% | $21.79 | -10.9% | COM | 80810D103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,088,706 | $13.69M | 3.8% | $15.85 | -5.0% | COM | 77313F106 |
| ZYME | ZYMEWORKS INC | 820,000 | $12M | 3.3% | $9.67 | +44.6% | COM | 98985Y108 |
| KURA | KURA ONCOLOGY INC | 1,325,000 | $11.54M | 3.2% | $13.30 | +8.2% | COM | 50127T109 |
| FOLD | AMICUS THERAPEUTICS INC | 920,000 | $8.666M | 2.4% | $10.39 | 0.0% | COM | 03152W109 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 80,000 | $8.45M | 2.3% | $116.71 | -9.2% | COM | 98956P102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 620,000 | $8.196M | 2.3% | $20.52 | -16.6% | COM | 87164F105 |
| STTK | SHATTUCK LABS INC | 6,638,935 | $8.033M | 2.2% | $5.19 | -76.2% | COM | 82024L103 |
| IMVT | IMMUNOVANT INC | 305,523 | $7.568M | 2.1% | $32.81 | -13.5% | COM | 45258J102 |
| — | BLUEPRINT MEDICINES CORP | 67,000 | $5.844M | 1.6% | $90.93 | — | COM | 09627Y109 |
| PRTA | PROTHENA CORP PLC | 418,122 | $5.791M | 1.6% | $26.88 | -41.3% | SHS | G72800108 |
| — | GALAPAGOS NV | 176,900 | $4.865M | 1.3% | — | — | Call | 36315X901 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,905,000 | $4.022M | 1.1% | $1.23 | -12.3% | COM | 23284F105 |
| HAE | HAEMONETICS CORP MASS | 46,700 | $3.646M | 1.0% | $80.79 | -0.6% | COM | 405024100 |
| CNC | CENTENE CORP DEL | 55,000 | $3.332M | 0.9% | $62.36 | 0.0% | COM | 15135B101 |
| SGHT | SIGHT SCIENCES INC | 908,847 | $3.308M | 0.9% | $5.83 | -21.8% | COM | 82657M105 |
| LIVN | LIVANOVA PLC | 70,000 | $3.242M | 0.9% | $49.57 | +3.5% | SHS | G5509L101 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 270,000 | $3.186M | 0.9% | $33.34 | -49.7% | COM NEW | 21833P301 |
| ERAS | ERASCA INC | 947,110 | $2.377M | 0.7% | $2.11 | +29.7% | COM | 29479A108 |
| SYRE | SPYRE THERAPEUTICS INC | 80,000 | $1.862M | 0.5% | $29.32 | 0.0% | COM NEW | 00773J202 |
| CDNA | CAREDX INC | 80,000 | $1.713M | 0.5% | $24.32 | 0.0% | COM | 14167L103 |
| — | MURAL ONCOLOGY PUB LTD CO | 466,822 | $1.503M | 0.4% | $5.09 | — | ORD SHS | G63365103 |
| FTRE | FORTREA HLDGS INC | 55,100 | $1.028M | 0.3% | $19.49 | 0.0% | COMMON STOCK | 34965K107 |
| RNTX | AILERON THERAPEUTICS INC | 404,979 | $931K | 0.3% | $3.64 | -16.9% | COM NEW | 00887A204 |
| IMNM | IMMUNOME INC | 54,342 | $577K | 0.2% | $14.65 | -17.5% | COM | 45257U108 |
| OKUR | ONKURE THERAPEUTICS INC | 63,754 | $548K | 0.2% | $15.14 | 0.0% | COM CL A | 68277Q105 |